Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Published on by Top Pharmaceutical

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Ms. Oliwia Kordyl, Poznan Univeristy of Medical Sciences, Poland

Ms. Oliwia Kordyl (b. June 9, 1997) is a dedicated PhD student at Poznan University of Medical Sciences, specializing in 3D printed microneedles for targeted drug delivery. With a background in biotechnology from Adam Mickiewicz University, her work spans molecular biology, pharmaceutical technology, and reproductive genetics. Oliwia has held roles as a lab manager, molecular biologist, and biotechnologist, contributing to innovative projects and scientific conferences. She is skilled in advanced lab techniques and passionate about travel, fitness, and continuous learning.

Publication Profile

orcid

Education

Ms. Oliwia Kordyl is currently pursuing her Ph.D. (Nov 2023–Present) at the Poznan University of Medical Sciences in Poland, focusing on 3D printed microneedles for voriconazole delivery in treating local skin infections. Her research involves optimizing microneedle manufacturing, assessing physicochemical and pharmaceutical properties in vitro, and evaluating drug permeation ex vivo and microbiological effectiveness 🧪🧬. She earned her M.Sc. and B.Sc. in biotechnology from Adam Mickiewicz University (2016–2021), where she explored DNA methylation in oligozoospermia and gene expression in spermatogenesis 🧫. Her academic journey began at K.K. Baczyński Secondary School, specializing in biology, physics, and chemistry 🔬📚.

Experience

Ms. Oliwia Kordyl completed a valuable internship at Novazym Polska in Poznań from July to August 2019. During her time at this renowned biotechnology company, she gained hands-on experience in laboratory techniques and deepened her understanding of industrial biotechnology practices 🔬💼. The internship provided her with practical insights into the daily operations of a biotech firm and allowed her to apply her academic knowledge in a real-world setting 🧪📊. This experience not only enhanced her technical skills but also strengthened her passion for research and innovation in the field of biotechnology, laying a strong foundation for her future scientific endeavors 🚀.

Awards

🏆 Ms. Oliwia Kordyl has actively contributed to the scientific community through speeches and posters at esteemed conferences. She presented on sperm DNA methylation at the 21st Andrology Day (2019) 🧬 and the 21st European Testis Workshop (2021) in Barcelona. Her posters featured at ESHRE 2020, the European Human Genetics Conference (2021), and the 6th Polish Congress of Genetics (2022) showcased her expertise in epigenetics and sperm chromatin structure 🧫📊. In 2023, she co-authored a poster on microneedles for transdermal drug delivery at PolGerSym10 💉. Oliwia also co-authored a publication in the International Journal of Molecular Sciences (2022) 📄📚.

Research Focus

Ms. Oliwia Kordyl’s research focuses on the development of innovative drug delivery systems, particularly microneedle-based technologies for transdermal applications. Her work combines 3D printing, pharmaceutical coatings, and hydrogel systems to enhance the treatment of bacterial and fungal skin infections. She also explores photodynamic therapy and nanotechnology for targeted drug release. Her interdisciplinary approach bridges materials science, biomedical engineering, and pharmaceutics. Additionally, her research extends to epigenetic analysis in human sperm, highlighting her interest in reproductive biology. Her work is at the frontier of personalized medicine, non-invasive therapies, and advanced pharmaceutical technologies.

Publication Top Notes

Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems

Microneedle-based arrays – Breakthrough strategy for the treatment of bacterial and fungal skin infections

Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology

Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males

Anna Lahuta-Drug Delivery Systems-Best Researcher Award-1015

Published on by Top Pharmaceutical

Dr.Anna Lahuta-Drug Delivery Systems-Best Researcher Award

V. N. Karazin Kharkiv National University-Ukrain

Author profile

Early Academic Pursuits

Dr.Anna Lahuta's academic journey began in September 2007 at V.N. Karazin Kharkiv National University in Ukraine, where she embarked on a rigorous course of study in chemistry. During her tenure as a student, Lahuta demonstrated exceptional aptitude and passion for the subject, earning both her Bachelor's and Master's degrees. Her dedication to her studies was evident through her continuous pursuit of knowledge, culminating in her postgraduate studies at the same institution. This period was marked by intensive research and academic growth, setting a solid foundation for her future career in chemical sciences.

Professional Endeavors

In October 2019, Anna Lahuta achieved a significant milestone by earning the degree of Candidate of Chemical Sciences, equivalent to a Doctor of Philosophy (Ph.D.). This achievement marked her transition from a dedicated student to a recognized expert in her field. Her academic career progressed swiftly as she took on the role of a senior research fellow and associate professor at V.N. Karazin Kharkiv National University. Since 2017, Lahuta has been actively involved in teaching and research, contributing to the academic community with her expertise and innovative ideas.

Contributions and Research Focus

Dr.Anna Lahuta's research interests are broad and impactful, focusing on various aspects of chemical sciences. Her work often explores the intersection of chemistry with other scientific disciplines, leading to innovative and interdisciplinary research outcomes. Lahuta's participation in multiple international internships has significantly enriched her research perspective. In 2016, she interned at the University of Nice Sophia Antipolis in France, where she gained valuable international experience and exposure to different research methodologies. She further broadened her horizons through internships at Aston University in Birmingham, UK, in September 2017 and again in May-June 2022. These experiences allowed her to collaborate with global experts, enhancing her research capabilities and fostering international collaborations.

Accolades and Recognition

Dr.Anna Lahuta's contributions to the field of chemical sciences have not gone unnoticed. Her academic and research endeavors have earned her recognition within the scientific community. Although specific awards and honors are not detailed, her rapid advancement to the role of associate professor and her involvement in prestigious international programs speak volumes about her reputation and the respect she commands among her peers. Lahuta's participation in the spring school ‘Academic English and Digital Teaching Methods’ in Greece in April 2023 and the summer school on “Developing Research Skills” in Greece in September 2023 further highlight her commitment to continuous professional development and excellence in academia.

Impact and Influence on Drug Delivery Systems

Through her teaching and research, Anna Lahuta has significantly impacted the academic and scientific communities. Her role as an associate professor involves not only imparting knowledge to students but also mentoring and guiding the next generation of chemists. Her research contributions have likely influenced various chemical sciences fields, promoting advancements and new understandings. Moreover, her international experiences have enabled her to bring diverse perspectives and methodologies into her work, benefiting her students and colleagues.

Legacy and Future Contributions

Dr. Anna Lahuta continues her career, her legacy is being built on a foundation of dedication, innovation, and excellence. Her commitment to research and teaching ensures that she will remain a significant figure in chemical sciences. Looking ahead, Lahuta is poised to make further contributions that will advance the field and inspire future generations of scientists. Her ongoing professional development and international collaborations will likely lead to new research opportunities and breakthroughs, cementing her status as a leading expert in her domain.

Modern DDS are highly engineered to overcome biological barriers and achieve controlled release profiles. For example, liposomes, nanoparticles, and dendrimers can be designed to target specific cells or tissues, reducing systemic toxicity and improving drug accumulation at the disease site. Innovations like polymer-based drug delivery allow for sustained release, reducing the need for frequent dosing and improving patient compliance. Additionally, stimuli-responsive systems, which release drugs in response to environmental triggers like pH or temperature, offer dynamic control over drug administration. Overall, the development and refinement of drug delivery systems are critical for advancing personalized medicine and improving the efficacy of therapeutic interventions

Conclusion

Dr.Anna Lahuta's academic and professional journey is a testament to her dedication and passion for chemical sciences. From her early days as a student to her current role as an associate professor at V.N. Karazin Kharkiv National University, she has consistently demonstrated excellence and a commitment to advancing knowledge in her field. Her international experiences and continuous professional development reflect her desire to stay at the forefront of scientific research and education. As she continues to contribute to the academic community, her impact and influence will undoubtedly grow, leaving a lasting legacy for future scholars and researchers.

Drug delivery systems (DDS) are sophisticated technologies designed to transport therapeutic agents to targeted sites in the body, ensuring optimal efficacy and minimal side effects. These systems can range from simple mechanisms like controlled-release pills to advanced technologies such as nanocarriers and bioresponsive hydrogels. The primary goal of DDS is to improve the pharmacokinetics and pharmacodynamics of drugs, ensuring that they reach the intended site of action in the right concentration and at the right time. By doing so, these systems can enhance the therapeutic outcomes for patients, particularly in treating chronic diseases, cancers, and infections where precise delivery is crucial.

Notable Publications

The Spectrophotometric Determination of the Patchy Surface Potential of Viruses Using pH-Sensitive Molecular Probes

Thermostability of native DNA bound to TiO2 nanoparticles under physiological-like conditions

Influence of various colloidal surfactants on the stability of MS2 bacteriophage suspension. The charge distribution on the PCV2 virus surface

DNA:TiO2 nanoparticle nanoassemblies: effect of temperature and nanoparticle concentration on aggregation